What is the latest information on the price list of Nintedanib in 2026? It is worth paying attention to.

Nintedanib (Nintedanib) is a targeted therapy drug, mainly used to treat idiopathic pulmonary fibrosis (IPF) and other types of lung diseases. With the clinical application and promotion of nintedanib, its price issue has gradually attracted widespread attention from patients and the medical community. The following is the latest information on nintedanib prices, covering domestic and international markets, and analyzes relevant factors.

1. Domestic market price

In China, the brand name of nintedanib’s original drug is Vigat (Ofev), and it has been included in the reimbursement scope of Class B drugs according to the national medical insurance policy. This means that patients who meet the indications can pay part of the cost through medical insurance. The common packaging specifications of nintedanib are 100mg 30 pills/box and 150mg 30 pills/box, and its market price is about more than 4,000 yuan.

2. International market price

The international market price of nintedanib is also affected by factors such as exchange rate fluctuations, import taxes, and local drug policies. In countries such as Turkey and India, the common specifications of nintedanib original drug (produced by Bayer) are 100mg 60 capsules and 150mg 60 capsules, and the price per box is about 4,000 to 5,000 yuan. This price is also affected by exchange rate changes, so prices may vary in different countries and regions.

3. Generic drug market

As the clinical application of nintedanib gradually becomes more popular, many countries have also begun to produce generic drugs. Generic versions of nintedanib are generally less expensive and have similar therapeutic effects to the brand-name drug. Common manufacturers of generic drugs include BDR Company of India, Grammark Pharmaceuticals of India, ASEAN Pharmaceuticals of Laos, etc. Take the generic drugs produced by BDR Company in India as an example. Its common specification is 100 mg, and the price per box is usually around 600 yuan (the price is affected by the exchange rate).

Overall, the price of nintedanib varies greatly in both domestic and international markets. Domestic patients can be partially reimbursed through medical insurance. Prices in the international market are closely related to exchange rate fluctuations, and the price of generic drugs is much lower than that of original drugs, providing an economic choice for some patients. Patients should choose the drug that suits them based on their personal circumstances, treatment needs and financial status.

Keyword tags:

nintedanib, Nintedanib, price, medical insurance reimbursement, generic drugs, original drugs, pulmonary fibrosis, drug market, drug prices

Reference materials:https://www.drugs.com/nintedanib.html